Matches in Nanopublications for { ?s ?p "[Mutations of p53 are clearly involved in the pathogenesis of Barrett's cancer for a subset of patients (46%), and the fact that we could detect mutations in premalignant Barrett's epithelium supports the hypothesis that p53 mutations may be a useful marker for patients at increased risk for development of invasive cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP516224.RAA36Q0-6EcFkmI20c3fmw-RVKiq-tV_d2K-XvbPz9pNQ130_assertion description "[Mutations of p53 are clearly involved in the pathogenesis of Barrett's cancer for a subset of patients (46%), and the fact that we could detect mutations in premalignant Barrett's epithelium supports the hypothesis that p53 mutations may be a useful marker for patients at increased risk for development of invasive cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516224.RAA36Q0-6EcFkmI20c3fmw-RVKiq-tV_d2K-XvbPz9pNQ130_provenance.
- assertion description "[Mutations of p53 are clearly involved in the pathogenesis of Barrett's cancer for a subset of patients (46%), and the fact that we could detect mutations in premalignant Barrett's epithelium supports the hypothesis that p53 mutations may be a useful marker for patients at increased risk for development of invasive cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Mutations of p53 are clearly involved in the pathogenesis of Barrett's cancer for a subset of patients (46%), and the fact that we could detect mutations in premalignant Barrett's epithelium supports the hypothesis that p53 mutations may be a useful marker for patients at increased risk for development of invasive cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Mutations of p53 are clearly involved in the pathogenesis of Barrett's cancer for a subset of patients (46%), and the fact that we could detect mutations in premalignant Barrett's epithelium supports the hypothesis that p53 mutations may be a useful marker for patients at increased risk for development of invasive cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1346616.RAjAr0ICW_S_szQmoXdN-SX8jeQZp-yeqTUadZILWNTFg130_assertion description "[Mutations of p53 are clearly involved in the pathogenesis of Barrett's cancer for a subset of patients (46%), and the fact that we could detect mutations in premalignant Barrett's epithelium supports the hypothesis that p53 mutations may be a useful marker for patients at increased risk for development of invasive cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1346616.RAjAr0ICW_S_szQmoXdN-SX8jeQZp-yeqTUadZILWNTFg130_provenance.
- NP1346618.RA8pCOLKCqthV40E3Ap5KCr5gSyUHKk5x24lrFqia1xcI130_assertion description "[Mutations of p53 are clearly involved in the pathogenesis of Barrett's cancer for a subset of patients (46%), and the fact that we could detect mutations in premalignant Barrett's epithelium supports the hypothesis that p53 mutations may be a useful marker for patients at increased risk for development of invasive cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1346618.RA8pCOLKCqthV40E3Ap5KCr5gSyUHKk5x24lrFqia1xcI130_provenance.